Mechanism of matrine inhibiting MRE11 lactylation and DNA damage repair in regulating cholangiocarcinoma sensitivity to I125 radiotherapy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
To investigate the mechanism by which matrine enhances the sensitivity of cholangiocarcinoma to I-125 radiotherapy through inhibiting MRE11 lactylation modification and DNA damage repair. HuCC-T1 human cholangiocarcinoma cells were treated with matrine and/or I-125 irradiation. Cell viability was assessed using CCK-8 assay, and cell apoptosis was detected by flow cytometry. Western blot was performed to analyze the expression of apoptosis-related proteins (BAX, BCL2, cleaved caspase-3, and cleaved PARP). Immunofluorescence was used to detect MRE11 and γ-H2AX expression. A nude mouse xenograft model was established to validate the findings in vivo. Matrine inhibited the proliferation of HuCC-T1 cells and induced apoptosis in a dose- and time-dependent manner. The combination of matrine and I-125 irradiation significantly enhanced DNA damage compared with I-125 alone. Mechanistically, matrine suppressed MRE11 lactylation modification, thereby inhibiting DNA damage repair. The in vivo experiments confirmed that matrine enhanced the therapeutic efficacy of I-125 radiotherapy in cholangiocarcinoma xenografts. Matrine enhances the sensitivity of cholangiocarcinoma to I-125 radiotherapy by inhibiting MRE11 lactylation modification and DNA damage repair, suggesting its potential as a radiosensitizer for cholangiocarcinoma treatment.
Fields of Study & Subjects
Cholangiocarcinoma and Gallbladder Cancer Studies
Radiation Therapy and Dosimetry
DNA Repair Mechanisms
Publication details
- Journal / source
- Journal of Radiation Research and Applied Sciences
- Volume
- 19
- Issue
- 2
- Pages
- 102336–102336
- Publication date
- 31 March 2026
- Language
- EN